Molecular Therapy: Oncolytics, Vol 24, Iss, Pp 417-428 (2022) Chamberlain, C A, Bennett, E P, Kverneland, A H, Svane, I M, Donia, M & Met, Ö 2022, ' Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy ', Molecular Therapy-Oncolytics, vol. 24, pp. 417-428 . https://doi.org/10.1016/j.omto.2022.01.004